COOPER COS INC/THE (COO)

US2166485019 - Common Stock

99.63  -0.23 (-0.23%)

After market: 99.63 0 (0%)

Fundamental Rating

6

Overall COO gets a fundamental rating of 6 out of 10. We evaluated COO against 188 industry peers in the Health Care Equipment & Supplies industry. COO has an excellent profitability rating, but there are some minor concerns on its financial health. COO has a correct valuation and a medium growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
COO had a positive operating cash flow in the past year.
In the past 5 years COO has always been profitable.
COO had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

COO's Return On Assets of 2.97% is fine compared to the rest of the industry. COO outperforms 76.47% of its industry peers.
The Return On Equity of COO (4.53%) is better than 75.40% of its industry peers.
COO has a Return On Invested Capital of 4.38%. This is in the better half of the industry: COO outperforms 75.94% of its industry peers.
COO had an Average Return On Invested Capital over the past 3 years of 4.13%. This is below the industry average of 8.30%.
The last Return On Invested Capital (4.38%) for COO is above the 3 year average (4.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.97%
ROE 4.53%
ROIC 4.38%
ROA(3y)12.18%
ROA(5y)9.5%
ROE(3y)17.23%
ROE(5y)14.16%
ROIC(3y)4.13%
ROIC(5y)4.98%

1.3 Margins

COO's Profit Margin of 9.45% is amongst the best of the industry. COO outperforms 85.56% of its industry peers.
In the last couple of years the Profit Margin of COO has grown nicely.
Looking at the Operating Margin, with a value of 16.90%, COO belongs to the top of the industry, outperforming 89.30% of the companies in the same industry.
COO's Operating Margin has been stable in the last couple of years.
The Gross Margin of COO (66.36%) is better than 69.52% of its industry peers.
In the last couple of years the Gross Margin of COO has remained more or less at the same level.
Industry RankSector Rank
OM 16.9%
PM (TTM) 9.45%
GM 66.36%
OM growth 3Y4.97%
OM growth 5Y-0.95%
PM growth 3Y-5.84%
PM growth 5Y8.19%
GM growth 3Y1.29%
GM growth 5Y0.36%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COO is destroying value.
The number of shares outstanding for COO has been reduced compared to 1 year ago.
Compared to 5 years ago, COO has less shares outstanding
COO has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.26 indicates that COO is not in any danger for bankruptcy at the moment.
COO has a Altman-Z score of 4.26. This is in the better half of the industry: COO outperforms 73.26% of its industry peers.
The Debt to FCF ratio of COO is 13.91, which is on the high side as it means it would take COO, 13.91 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 13.91, COO is doing good in the industry, outperforming 71.12% of the companies in the same industry.
COO has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.33, COO perfoms like the industry average, outperforming 45.99% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 13.91
Altman-Z 4.26
ROIC/WACC0.51
WACC8.64%

2.3 Liquidity

A Current Ratio of 1.99 indicates that COO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.99, COO is doing worse than 68.45% of the companies in the same industry.
COO has a Quick Ratio of 1.18. This is a normal value and indicates that COO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.18, COO is doing worse than 72.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.18

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.80% over the past year.
COO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.13% yearly.
COO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.25%.
Measured over the past years, COO shows a small growth in Revenue. The Revenue has been growing by 7.24% on average per year.
EPS 1Y (TTM)16.8%
EPS 3Y9.91%
EPS 5Y2.13%
EPS Q2Q%14.63%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y13.91%
Revenue growth 5Y7.24%
Sales Q2Q%7.8%

3.2 Future

COO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.34% yearly.
COO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.67% yearly.
EPS Next Y15.46%
EPS Next 2Y13.46%
EPS Next 3Y12.88%
EPS Next 5Y11.34%
Revenue Next Year8.74%
Revenue Next 2Y8.17%
Revenue Next 3Y7.7%
Revenue Next 5Y6.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.22, which means the current valuation is very expensive for COO.
Based on the Price/Earnings ratio, COO is valued a bit cheaper than the industry average as 78.07% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.53, COO is valued at the same level.
Based on the Price/Forward Earnings ratio of 24.18, the valuation of COO can be described as rather expensive.
78.61% of the companies in the same industry are more expensive than COO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, COO is valued at the same level.
Industry RankSector Rank
PE 28.22
Fwd PE 24.18

4.2 Price Multiples

77.01% of the companies in the same industry are more expensive than COO, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COO indicates a somewhat cheap valuation: COO is cheaper than 70.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 104.87
EV/EBITDA 21.89

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COO does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of COO may justify a higher PE ratio.
A more expensive valuation may be justified as COO's earnings are expected to grow with 12.88% in the coming years.
PEG (NY)1.83
PEG (5Y)13.25
EPS Next 2Y13.46%
EPS Next 3Y12.88%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.67, COO pays a better dividend. On top of this COO pays more dividend than 89.84% of the companies listed in the same industry.
With a Dividend Yield of 0.02, COO pays less dividend than the S&P500 average, which is at 2.22.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

On average, the dividend of COO grows each year by 10.52%, which is quite nice.
COO has been paying a dividend for at least 10 years, so it has a reliable track record.
COO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years0
Div Non Decr Years15

5.3 Sustainability

0.42% of the earnings are spent on dividend by COO. This is a low number and sustainable payout ratio.
The dividend of COO is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP0.42%
EPS Next 2Y13.46%
EPS Next 3Y12.88%

COOPER COS INC/THE

NASDAQ:COO (11/15/2024, 8:01:04 PM)

After market: 99.63 0 (0%)

99.63

-0.23 (-0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.84B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.22
Fwd PE 24.18
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.83
PEG (5Y)13.25
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 4.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 16.9%
PM (TTM) 9.45%
GM 66.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.99
Quick Ratio 1.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)16.8%
EPS 3Y9.91%
EPS 5Y
EPS Q2Q%
EPS Next Y15.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.25%
Revenue growth 3Y13.91%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y